Cargando…

Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients

BACKGROUND: The Bladder Cancer Index (BCI) and Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-Bl-Cys) were developed to measure disease-specific health-related quality of life (HRQOL) in bladder cancer patients and patients treated with radical cystectomy, respectively. Both patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Michels, Charlotte T. J., Wijburg, Carl J., Abma, Inger L., Witjes, J. Alfred, Grutters, Janneke P. C., Rovers, Maroeska M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745039/
https://www.ncbi.nlm.nih.gov/pubmed/31522328
http://dx.doi.org/10.1186/s41687-019-0149-7
_version_ 1783451471631613952
author Michels, Charlotte T. J.
Wijburg, Carl J.
Abma, Inger L.
Witjes, J. Alfred
Grutters, Janneke P. C.
Rovers, Maroeska M.
author_facet Michels, Charlotte T. J.
Wijburg, Carl J.
Abma, Inger L.
Witjes, J. Alfred
Grutters, Janneke P. C.
Rovers, Maroeska M.
author_sort Michels, Charlotte T. J.
collection PubMed
description BACKGROUND: The Bladder Cancer Index (BCI) and Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-Bl-Cys) were developed to measure disease-specific health-related quality of life (HRQOL) in bladder cancer patients and patients treated with radical cystectomy, respectively. Both patient-reported outcome measures (PROMs) are frequently used in clinical practice, but are not yet validated according to the COSMIN criteria and not yet available in Dutch. Therefore, the aim of this study was to translate the BCI and FACT-Bl-Cys into Dutch and to evaluate their measurement properties according to the COSMIN criteria. METHODS: The BCI and FACT-Bl-Cys were translated into Dutch using a forward-backward method, and subsequently administered at baseline (pre-operatively) and 3 months post-operatively in bladder cancer patients who received a radical cystectomy. Validity (content and construct), reliability (internal consistency, test-retest reliability, and measurement error), floor and ceiling effects, and responsiveness were assessed according to the COSMIN criteria. RESULTS: Forward-backward translation encountered no particular linguistic problems. In total 260 patients completed the baseline measurement, while 182 patients completed the three-month measurement. Only a ceiling effect was identified for the BCI. Hypotheses testing for construct validity was satisfying, as 67% and 92% of the hypothesized correlations were confirmed. Structural validity was moderate for both measures, as confirmatory factor analyses showed limited fit. Reliability of both PROMs was good. The intraclass correlation coefficient (ICC) of the BCI domains ranged from 0.47 to 0.93, minimal value of Cronbach’s α was 0.70, smallest detectable change on group level (SDC group) ranged from 1.9 to 8.6. The ICC of the FACT-Bl-Cys domains ranged from 0.43 to 0.83, minimal value of Cronbach’s α was 0.77, SDC group was around 1. Only the FACT-Bl-Cys total score was found to be responsive to changes in generic quality of life. CONCLUSIONS: The Dutch versions of the BCI and FACT-Bl-Cys were shown to be reliable and have good content validity. Structural validity was limited for both measures. Only the FACT-Bl-Cys total score was responsive to changes in generic HRQOL. Despite some limitations, both PROMs seem suitable for use in clinical practice and research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41687-019-0149-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6745039
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-67450392019-09-27 Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients Michels, Charlotte T. J. Wijburg, Carl J. Abma, Inger L. Witjes, J. Alfred Grutters, Janneke P. C. Rovers, Maroeska M. J Patient Rep Outcomes Research BACKGROUND: The Bladder Cancer Index (BCI) and Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-Bl-Cys) were developed to measure disease-specific health-related quality of life (HRQOL) in bladder cancer patients and patients treated with radical cystectomy, respectively. Both patient-reported outcome measures (PROMs) are frequently used in clinical practice, but are not yet validated according to the COSMIN criteria and not yet available in Dutch. Therefore, the aim of this study was to translate the BCI and FACT-Bl-Cys into Dutch and to evaluate their measurement properties according to the COSMIN criteria. METHODS: The BCI and FACT-Bl-Cys were translated into Dutch using a forward-backward method, and subsequently administered at baseline (pre-operatively) and 3 months post-operatively in bladder cancer patients who received a radical cystectomy. Validity (content and construct), reliability (internal consistency, test-retest reliability, and measurement error), floor and ceiling effects, and responsiveness were assessed according to the COSMIN criteria. RESULTS: Forward-backward translation encountered no particular linguistic problems. In total 260 patients completed the baseline measurement, while 182 patients completed the three-month measurement. Only a ceiling effect was identified for the BCI. Hypotheses testing for construct validity was satisfying, as 67% and 92% of the hypothesized correlations were confirmed. Structural validity was moderate for both measures, as confirmatory factor analyses showed limited fit. Reliability of both PROMs was good. The intraclass correlation coefficient (ICC) of the BCI domains ranged from 0.47 to 0.93, minimal value of Cronbach’s α was 0.70, smallest detectable change on group level (SDC group) ranged from 1.9 to 8.6. The ICC of the FACT-Bl-Cys domains ranged from 0.43 to 0.83, minimal value of Cronbach’s α was 0.77, SDC group was around 1. Only the FACT-Bl-Cys total score was found to be responsive to changes in generic quality of life. CONCLUSIONS: The Dutch versions of the BCI and FACT-Bl-Cys were shown to be reliable and have good content validity. Structural validity was limited for both measures. Only the FACT-Bl-Cys total score was responsive to changes in generic HRQOL. Despite some limitations, both PROMs seem suitable for use in clinical practice and research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41687-019-0149-7) contains supplementary material, which is available to authorized users. Springer International Publishing 2019-09-14 /pmc/articles/PMC6745039/ /pubmed/31522328 http://dx.doi.org/10.1186/s41687-019-0149-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Michels, Charlotte T. J.
Wijburg, Carl J.
Abma, Inger L.
Witjes, J. Alfred
Grutters, Janneke P. C.
Rovers, Maroeska M.
Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients
title Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients
title_full Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients
title_fullStr Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients
title_full_unstemmed Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients
title_short Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients
title_sort translation and validation of two disease-specific patient-reported outcome measures (bladder cancer index and fact-bl-cys) in dutch bladder cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745039/
https://www.ncbi.nlm.nih.gov/pubmed/31522328
http://dx.doi.org/10.1186/s41687-019-0149-7
work_keys_str_mv AT michelscharlottetj translationandvalidationoftwodiseasespecificpatientreportedoutcomemeasuresbladdercancerindexandfactblcysindutchbladdercancerpatients
AT wijburgcarlj translationandvalidationoftwodiseasespecificpatientreportedoutcomemeasuresbladdercancerindexandfactblcysindutchbladdercancerpatients
AT abmaingerl translationandvalidationoftwodiseasespecificpatientreportedoutcomemeasuresbladdercancerindexandfactblcysindutchbladdercancerpatients
AT witjesjalfred translationandvalidationoftwodiseasespecificpatientreportedoutcomemeasuresbladdercancerindexandfactblcysindutchbladdercancerpatients
AT gruttersjannekepc translationandvalidationoftwodiseasespecificpatientreportedoutcomemeasuresbladdercancerindexandfactblcysindutchbladdercancerpatients
AT roversmaroeskam translationandvalidationoftwodiseasespecificpatientreportedoutcomemeasuresbladdercancerindexandfactblcysindutchbladdercancerpatients